Skip to main content
E

Eluciderm

Eluciderm develops a topical formulation that promotes scarless wound healing by minimizing dermal fibrosis through targeted delivery of active compounds. This product addresses the challenge of excessive scarring in wound recovery, enhancing patient outcomes and skin integrity.

Traction 3/10
San Diego, United States · HQ
Founded 2018110+ followers
  • Biotechnology
Updated 7 months ago

Funding

Raised to date

$7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

John Delgado

Chief Medical Officer/Researcher/Physician

Product

Features

  • Eluciderm develops a topical formulation that promotes scarless wound healing by minimizing dermal fibrosis through targeted delivery of active compounds. This product addresses the challenge of excessive scarring in wound recovery, enhancing patient outcomes and skin integrity.
This profile is AI-generated and may contain inaccuracies.